Covering top Late-Breaking Clinical Trials from Day 2 of ACC.22, JACC Editor-in-Chief Valentin Fuster, MD, PhD, MACC, is joined by Biykem Bozkurt MD, PhD, FACC; Joanna Chikwe, MD, FACC; Paul L. Douglass, MD, MACC; and Viviany R Taqueti, MD, MPH, FACC, in a trial-by-trial breakdown of the day's most influential late-breaking science, including:

• TRANSLATE-TIMI 70: Effect of Vupanorsen on Non-high-density Lipoprotein Cholesterol Levels In Statin-treated Patients With Elevated Cholesterol
• PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial
• Updated Cumulative Results of Treatment With Mavacamten From the EXPLORER-LTE Cohort of the MAVA-LTE Study in Patients With Obstructive Hypertrophic Cardiomyopathy

A long-standing resource for busy cardiovascular professionals, ACC Cardiology Hour provides expert analysis and key takeaways on top clinical trials released during cardiology's biggest meetings. Visit JACC.org/CardiologyHour for more information.

Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Atherosclerotic Disease (CAD/PAD), Cardiac Surgery, Cardio-Oncology, Congenital Heart Disease and Pediatric Cardiology, Dyslipidemia, Geriatric Cardiology, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Pericardial Disease, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Sports and Exercise Cardiology, Stable Ischemic Heart Disease, Valvular Heart Disease, Vascular Medicine

Keywords: ACC Annual Scientific Session, ACC22

< Back to Listings